|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 中国绿色低碳住区减碳技术评估框架体系 讨论稿节选显示文摘低碳建筑已成为建筑界,产业界普遍关注的问题。但国内外学术界至今对'低碳建筑'并未作出明确科学的界定。要科学地界定低碳建筑需要确定各类建筑低碳排放的标准,同时要建立起建筑碳排放的计算方法和评估办法。这是一个需要多学科多专业共同认真研究的课题。全国工商联房地产商会邀请建筑界部分专家对住宅区减碳排放问题进行了多次讨论,在此基础上提出了'中国绿色低碳住区减碳技术评估框架体系'讨论稿。讨论稿提出了'低碳住区'的技术要点,构建原则及减碳评估指标。对住区建筑节能,节水,住区绿化,住区交通以及住区建造期、运行期的许多技术措施提出了量化的计算方法。对住区各个系统的减碳减排放状况提出了评价办法。讨论稿提出的评估框架体系试图为住宅区的减碳计算和评估提出一个可以实际应用的技术方法。这是我们看到的国内第一个提出的系统的减碳技术评估框架体系。这个讨论稿尽管是邀请各方面建筑专家经数次讨论而成,但这毕竟是'一家'之言。讨论稿中所确定的计算方法是否科学,对碳排放状况的评价方法是否合理等等,都有待于进一步研究和论证。既是讨论稿,稿中的论点、公式、方法就可能有不全面、不准确、不科学的部分。这个讨论稿共有5章,核心内容是2~4章。限于篇幅本刊将讨论稿最核心的2~4章全文发表。希望引起业内人士的关注和讨论。 | China Real Estate Chamber of Commerce, Elite (China) Real Estate Academy | 2010 | 动感(生态城市与绿色建筑)2010，0，1： | 2 |
| 2 | On-line parallel reversed phase two-dimensional liquid chromatography for high-throughput analysis of complex proteomic samples显示文摘A comprehensive two-dimensional liquid chromatographic system (2D SCX/RP) is con- structed with a 10-port-2-way valve using strong cation exchange chromatography (Hypersil SCX, 100 mm×4.6 mm I.D.) followed by reversed phase chromatography (Hypersil BDS C18, 15 mm×4.6 mm I.D.) to separate the complex peptides from globin peptic hydrolysate. After the sample was loaded on the SCX column, the phosphate buffer (pH 4.0) was used to elute the peptides. Then, elutes flowed through the interface and the peptides focused on the head of the trapping columns (Hypersil BDS C18, 15 mm×4.6 mm I.D.) but salt passed into the waste. After the valve was switched, the samples were flushed with a backward flow into the RP analytical column. The peptides on the SCX were eluted with 12 discontinuous steps linearly increasing salt concentrations. The peptides enriched on the trapping column were desalted and separated by the RP columns. The resolution and the resolved peaks of the 2D SCX/RP system were greatly increased and the total peak capacity reached as high as 2280. | WANG Zhicong1,3, ZHANG Qinghe2, LI Tong2, ZHAO Zhongyi3 & ZHANG Weibing1 1. Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116011, China 2. Dalian Elite Analytical Instrument Co., Ltd., Dalian 116011, China 3. Faculty of Material Science and Chemical Engineering, China University of Geosciences, Wuhan 430074, China | 2006 | Science China Chemistry2006，49，6： | 2 |
| 3 | Intraperitoneal chemotherapy in the first-line treatment of women with stage Ⅲ epithelial ovarian cancer: a systematic review with metaanalyses显示文摘 | Elit L Oliver TK Covens A | 2007 | Cancer2007，109，4： | 1 |
| 4 | Cervical cancer in the older woman显示文摘 | Elit L | 2014 | Maturitas2014，78，3： | 1 |
| 5 | Pitfalls in the diagnosis of cervical intraepithelial neopla- sia 1 显示文摘 | Elit LM | 2004 | J Low Genit Tract Dis2004，8，3： | 1 |
| 6 | A phase II study of temsirolimus (CCI-779) in patients with metastatic and/or locally advanced recurrent endometrial cancer previously treated with chemotherapy 显示文摘 | Oza A Elit L Provencher D | 2008 | J Clin Oncol2008，26，15： | 1 |
| 7 | Intraperitoneal chemotherapy in the first-line treatment of women with stage Ⅲ epithelial ovarian cancer:a systematic review with metaanalyses显示文摘 | Elit L Oliver TK Covens A | 2007 | Cancer2007，109，： | 1 |
| 8 | Phase II study of erlotinib inrecurrent or metastatic endometrial cancer: NCIC IND-148 显示文摘 | Oza A M Eisenhauer E A Elit L | 2008 | J Clin Oncol2008，26，26： | 1 |
| 9 | Assessment of 2 cervical screening methods in Mongolia: cervical cytology and visual inspection with acetic acid显示文摘 | Elit L Baigal G Tan J | 2006 | J Low Genit Tract Dis2006，10，2： | 1 |
| 10 | CA125 response as a marker of clinical benefit in patients with recurrent ovarian cancer treated with gemcitabine and sorafenib-a trial of the PMH phase II consortium显示文摘 | Welch S Hirte H Elit L | | 0，，18： | 1 |
| 11 | Race, cultural capital and the educational effects of participation in sports显示文摘 | EITLE T ELITE D | 2002 | Soc Edu2002，75，2： | 1 |
| 12 | Follow-up after primary therapy for endometrial cancer: a systematic review 显示文摘 | Fung-Kee-Fung M Dodge J Elit L | 2006 | Gynecol Oncol2006，101，： | 1 |
| 13 | Phase ]/ study of temsirolimus in women with recurrent or metastatic endometrial cancer : a trial of the NCIC Clinical Trials Group显示文摘 | Oza AM Elit L Tsao MS | 2011 | J Clin Oncol2011，29，24： | 1 |
| 14 | Management of advanced or recurrent cervicalcancer: chemotherapy and beyond 显示文摘 | Elit LM Hirte H | 2014 | Expert review of anticancertherapy2014，14，3： | 1 |
| 15 | Women's perceptions about treatment decision making for ovarian cancer显示文摘 | L Elit C Charles I Gold | 2003 | Gynecologic Oncology2003，88，： | 1 |
| 16 | Role of cervical screening in older women显示文摘 | Elit L | 2014 | Maturitas2014，79，4： | 1 |
| 17 | The challenge of understanding cerebral white matter injury in the premature infant 显示文摘 | Elit CM Rosenberg PA | 2014 | Neuroscience2014，276，： | 1 |
| 18 | Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial显示文摘 | Dan Stark Matthew Nankivell Eric Pujade-Lauraine Gunnar Kristensen Lorraine Elit Martin Stockler Felix Hilpert Andrés Cervantes Julia Brown Anne Lanceley Galina Velikova Eduardo Sabate Jacobus Pfisterer Mark S Carey Philip Beale Wendi Qian Ann Marie Swart | 2013 | Lancet Oncology2013，，： | 1 |
| 19 | Follow-up after pri- mary therapy for endometrial cancer: a systematic review 显示文摘 | Fung-Kee-Fung M Dodge J Elit L | 2006 | Gynecol Oncol2006，101，： | 1 |
| 20 | 显示文摘 | STRAY-Gundersen et Living high-traininp low altitrde training improves sea level performance in male and female elite runners | 2001 | J Appl physiol2001，，91： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员